Is Hangzhou Tigermed stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Hangzhou Tigermed pays dividends. Last time was Thursday 1st of August 2024 where the investors holding the stock on Tuesday 11th of June 2024 were paid $0.079775 per share. Over the last 2 times between 2023 and 2024, Hangzhou Tigermed has paid $0.158334 with an average of $0.08 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Hangzhou Tigermed 10 years ago, but if you had invested on Monday 11th of July 2022 when the price was $12.75, you would have made a loss of $-8.61 per share or -67.53%
No, the average daily trading liquidity for Hangzhou Tigermed is $25 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Hangzhou Tigermed has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.16, the company's ability to pay off the debt is normal. Hangzhou Tigermed has a good net profit margin of 14.11% and should have high tolerances against inflation.
We have calculated the inflation risk for Hangzhou Tigermed to be low [0.4 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.